From: A potential synbiotic product improves the lipid profile of diabetic rats
   Groups | Group I | Group II | Group III | Group IV |
---|---|---|---|---|
Parameters/ | ||||
Time | ||||
 Triglycerides |  | |||
  T0 | 135.10B.a ± 12.62 | 173.73B.a ± 11.46 | 156.64B.a ± 12.51 | 175.36C.a ± 13.37 |
  T2 | 188.82A.b ± 12.90 | 425.33AB.a ± 84.89 | 396.18A.a ± 49.70 | 348.50AB.a ± 31.14 |
  T3 | 149.55AB.c ± 9.95 | 628.67A.a ± 32.05 | 503.25A.b ± 25.79 | 419.00A.b ± 35.39 |
Total cholesterol | Â | |||
  T0 | 101.37A.a ± 4.66 | 111.73 A.a ± 3.33 | 99.64A.a ± 2.81 | 98.9A.a ± 2.71 |
  T2 | 80.78B.b ± 3.30 | 100.79A.a ± 4.97 | 102.46A.a ± 3.73 | 100.25A.a ± 4.07 |
  T3 | 69.82B.b ± 5.52 | 96.78A.a ± 5.61 | 97.64A.a ± 2.96 | 90.33A.a ± 4.84 |
 HDL-C |  | |||
  T0 | 45.27A.a ± 1.92 | 55.82A.a ± 3.64 | 50.09A.a ± 1.66 | 52.82A.a ± 3.25 |
  T2 | 43.82A.a ± 2.59 | 52.40 A.a ± 2.20 | 48.64A.a ± 1.50 | 48.70A.a ± 2.25 |
  T3 | 34.37B.c ± 2.13 | 52.44A.b ± 1.70 | 52.27A.b ± 1.61 | 65.00A.a ± 6.36 |
 nHDL-C |  | |||
  T0 | 39.56B.a ± 2.35 | 48.57A.a ± 2.81 | 48.63A.a ± 2.15 | 45.50A.a ± 3.01 |
  T2 | 35.46B.a ± 4.19 | 48.13A.a ± 3.93 | 45.37A.a ± 2.66 | 39.40A.a ± 2.16 |
  T3 | 56.09A.a ± 3.60 | 55.91A.a ± 3.88 | 49.55A.a ± 2.92 | 46.09 A.a ± 3.19 |